SEZI — Senzime AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK660.30m
- SEK626.74m
- SEK104.02m
Brief: Senzime Expands Production Capacity On Increasing Market Demand
Brief: Senzime Gets Granted European Patent For Tetrasens
Brief: Senzime Outlicenses Exspiron In Chinese Market
Brief: Senzime YTD May 2023 Sales Have Tripled Compared To Same Period Last Year
Brief: Senzime Expands Partnership With Japanese Licensee
Brief: Senzime Sees Continued High Demand On Main Markets For 2023
Brief: Senzime Q1 EBITDA at SEK -26.5 Million
Brief: Senzime Raises SEK 91.9 Million Through Rights Issue
Brief: Senzime Gets Approval For Its Pediatric Sensor In Japan
Brief: Senzime Q4 EBITDA Loss Widens To SEK 37.5 Mln
Brief: Senzime Wins Large Order For Its Pediatric Sensor In US
Brief: Senzime Resolves On Rights Issue Of About SEK 100 Mln
Brief: Senzime Preliminary Q4 Sales Rise To SEK 4.6 Mln
Brief: Senzime Receives Contract For Tetrasens Pediatric In U.S.
Brief: Senzime Estimates Net Sales To Reach SEK 275 Mln - 325 Mln By 2025
Brief: Senzime Q3 EBITDA Loss Widens To SEK 24.7 Mln
Brief: Senzime Says ASA Approves Guidelines For Neuromuscular Blockade Monitoring
Brief: Senzime: New Study Confirms Effectiveness Of Tetragraph
Brief: Senzimes Receives FDA 510k-Clearance For New Disposable Sensor